{"id":42555,"date":"2025-09-30T16:11:42","date_gmt":"2025-09-30T08:11:42","guid":{"rendered":"https:\/\/flcube.com\/?p=42555"},"modified":"2025-09-30T16:11:43","modified_gmt":"2025-09-30T08:11:43","slug":"shanghai-junshi-biosciences-announces-nearly-rmb-380-million-capital-increase-for-grit-biotechnology","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=42555","title":{"rendered":"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology"},"content":{"rendered":"\n<p><strong>Shanghai Junshi Biosciences Co., Ltd. (<a href=\"https:\/\/www.google.com\/finance\/quote\/1877:HKG\">HKG: 1877<\/a>, <a href=\"https:\/\/www.google.com\/finance\/quote\/688180:SHA\">SHA: 688180<\/a>)<\/strong> disclosed that its subsidiary, <strong>Shanghai JunTop Biosciences Co., Ltd.<\/strong>, together with a consortium of institutional investors, will increase their holdings in <strong>Beijing Grit Biotechnology Co., Ltd.<\/strong> The new capital injection totals <strong>RMB\u202f380\u202fmillion<\/strong> (\u2248\u202fUSD\u202f55\u202fmillion) and values Grit Bio at <strong>RMB\u202f1.45\u202fbillion<\/strong> pre\u2011investment.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-investment-structure\">Investment Structure<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Investor<\/th><th>Shares<\/th><th>Capital<\/th><th>Notes<\/th><\/tr><\/thead><tbody><tr><td>Shanghai JunTop Biosciences<\/td><td>1,280,623<\/td><td>RMB\u202f80\u202fmillion<\/td><td>Primary lead investor<\/td><\/tr><tr><td>Shanghai Tanying Investment Partnership<\/td><td>640,311<\/td><td>RMB\u202f40\u202fmillion<\/td><td>Existing shareholder<\/td><\/tr><tr><td>Seven additional investors<\/td><td>4,157,098<\/td><td>RMB\u202f259.7\u202fmillion<\/td><td>Bulk participation<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-valuation-drivers\">Valuation Drivers<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Core Program Progress<\/strong> \u2013 Robust data from <strong>GT101<\/strong> (Phase\u202fII) and <strong>GT201<\/strong> (Phase\u202fI) TIL therapies.<\/li>\n\n\n\n<li><strong>Early\u2011Stage Pipeline<\/strong> \u2013 Multiple pre\u2011clinical candidates with rapid development timelines.<\/li>\n\n\n\n<li><strong>Market Position<\/strong> \u2013 First\u2011in\u2011class TIL drug in China, expanding into the global IL\u201115 complex arena.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-grit-biotechnology-s-focus\">Grit Biotechnology\u2019s Focus<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Tumor\u2011Infiltrating Lymphocyte (TIL) Technology<\/strong> \u2013 Engineered autologous T cells that recognize tumor\u2011specific antigens.<\/li>\n\n\n\n<li><strong>GT101 Injection<\/strong> \u2013 First Chinese TIL product approved for registered clinical trials; now in pivotal Phase\u202fII.<\/li>\n\n\n\n<li><strong>GT201 Injection<\/strong> \u2013 Global first membrane\u2011bound IL\u201115 complex TIL; IND filings completed in China and the U.S., advancing to Phase\u202fI.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h3>\n\n\n\n<p>The capital raise positions Grit Bio to accelerate its clinical program, expand manufacturing capacity, and pursue additional regulatory approvals. For Junshi Biosciences, the move deepens its footprint in the burgeoning tumor immunotherapy market and strengthens synergies with its own biotech portfolio.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-market-outlook\">Market Outlook<\/h3>\n\n\n\n<p>China\u2019s immuno\u2011oncology market is projected to surpass <strong>USD\u202f10\u202fbillion<\/strong> by 2030, with TIL therapies gaining traction as a personalized, off\u2011the\u2011shelf alternative to CAR\u2011T. The new investment is poised to secure Grit Bio\u2019s leadership in this high\u2011growth niche.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2025092903027_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2025092903027_c.\"><\/object><a id=\"wp-block-file--media-9c68e80f-dabc-4c8a-8be9-7944ca67761d\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2025092903027_c.pdf\">2025092903027_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2025092903027_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-9c68e80f-dabc-4c8a-8be9-7944ca67761d\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877, SHA: 688180) disclosed that its subsidiary, Shanghai JunTop&#8230;<\/p>\n","protected":false},"author":1,"featured_media":42557,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[16,542,899,296,3230,900],"class_list":["post-42555","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-cancer","tag-grit-biotechnology","tag-hkg-1877","tag-junshi-biosciences","tag-juntop-biosciences","tag-sha-688180"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877, SHA: 688180) disclosed that its subsidiary, Shanghai JunTop Biosciences Co., Ltd., together with a consortium of institutional investors, will increase their holdings in Beijing Grit Biotechnology Co., Ltd. The new capital injection totals RMB\u202f380\u202fmillion (\u2248\u202fUSD\u202f55\u202fmillion) and values Grit Bio at RMB\u202f1.45\u202fbillion pre\u2011investment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=42555\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology\" \/>\n<meta property=\"og:description\" content=\"Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877, SHA: 688180) disclosed that its subsidiary, Shanghai JunTop Biosciences Co., Ltd., together with a consortium of institutional investors, will increase their holdings in Beijing Grit Biotechnology Co., Ltd. The new capital injection totals RMB\u202f380\u202fmillion (\u2248\u202fUSD\u202f55\u202fmillion) and values Grit Bio at RMB\u202f1.45\u202fbillion pre\u2011investment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=42555\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-30T08:11:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-30T08:11:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3008.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42555#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42555\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology\",\"datePublished\":\"2025-09-30T08:11:42+00:00\",\"dateModified\":\"2025-09-30T08:11:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42555\"},\"wordCount\":286,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42555#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3008.webp\",\"keywords\":[\"Cancer\",\"GRIT Biotechnology\",\"HKG: 1877\",\"Junshi Biosciences\",\"JunTop Biosciences\",\"SHA: 688180\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42555#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42555\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=42555\",\"name\":\"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42555#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42555#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3008.webp\",\"datePublished\":\"2025-09-30T08:11:42+00:00\",\"dateModified\":\"2025-09-30T08:11:43+00:00\",\"description\":\"Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877, SHA: 688180) disclosed that its subsidiary, Shanghai JunTop Biosciences Co., Ltd., together with a consortium of institutional investors, will increase their holdings in Beijing Grit Biotechnology Co., Ltd. The new capital injection totals RMB\u202f380\u202fmillion (\u2248\u202fUSD\u202f55\u202fmillion) and values Grit Bio at RMB\u202f1.45\u202fbillion pre\u2011investment.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42555#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42555\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42555#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3008.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3008.webp\",\"width\":1080,\"height\":608,\"caption\":\"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42555#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology - Insight, China&#039;s Pharmaceutical Industry","description":"Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877, SHA: 688180) disclosed that its subsidiary, Shanghai JunTop Biosciences Co., Ltd., together with a consortium of institutional investors, will increase their holdings in Beijing Grit Biotechnology Co., Ltd. The new capital injection totals RMB\u202f380\u202fmillion (\u2248\u202fUSD\u202f55\u202fmillion) and values Grit Bio at RMB\u202f1.45\u202fbillion pre\u2011investment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=42555","og_locale":"en_US","og_type":"article","og_title":"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology","og_description":"Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877, SHA: 688180) disclosed that its subsidiary, Shanghai JunTop Biosciences Co., Ltd., together with a consortium of institutional investors, will increase their holdings in Beijing Grit Biotechnology Co., Ltd. The new capital injection totals RMB\u202f380\u202fmillion (\u2248\u202fUSD\u202f55\u202fmillion) and values Grit Bio at RMB\u202f1.45\u202fbillion pre\u2011investment.","og_url":"https:\/\/flcube.com\/?p=42555","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-30T08:11:42+00:00","article_modified_time":"2025-09-30T08:11:43+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3008.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=42555#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=42555"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology","datePublished":"2025-09-30T08:11:42+00:00","dateModified":"2025-09-30T08:11:43+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=42555"},"wordCount":286,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=42555#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3008.webp","keywords":["Cancer","GRIT Biotechnology","HKG: 1877","Junshi Biosciences","JunTop Biosciences","SHA: 688180"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=42555#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=42555","url":"https:\/\/flcube.com\/?p=42555","name":"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=42555#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=42555#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3008.webp","datePublished":"2025-09-30T08:11:42+00:00","dateModified":"2025-09-30T08:11:43+00:00","description":"Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877, SHA: 688180) disclosed that its subsidiary, Shanghai JunTop Biosciences Co., Ltd., together with a consortium of institutional investors, will increase their holdings in Beijing Grit Biotechnology Co., Ltd. The new capital injection totals RMB\u202f380\u202fmillion (\u2248\u202fUSD\u202f55\u202fmillion) and values Grit Bio at RMB\u202f1.45\u202fbillion pre\u2011investment.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=42555#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=42555"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=42555#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3008.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3008.webp","width":1080,"height":608,"caption":"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=42555#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Shanghai Junshi Biosciences Announces Nearly RMB\u202f380\u202fMillion Capital Increase for Grit Biotechnology"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3008.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42555","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42555"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42555\/revisions"}],"predecessor-version":[{"id":42558,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42555\/revisions\/42558"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/42557"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42555"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=42555"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=42555"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}